Literature DB >> 33241607

Generalizing randomized trial findings to a target population using complex survey population data.

Benjamin Ackerman1, Catherine R Lesko2, Juned Siddique3, Ryoko Susukida4, Elizabeth A Stuart1,4,5.   

Abstract

Randomized trials are considered the gold standard for estimating causal effects. Trial findings are often used to inform policy and programming efforts, yet their results may not generalize well to a relevant target population due to potential differences in effect moderators between the trial and population. Statistical methods have been developed to improve generalizability by combining trials and population data, and weighting the trial to resemble the population on baseline covariates. Large-scale surveys in fields such as health and education with complex survey designs are a logical source for population data; however, there is currently no best practice for incorporating survey weights when generalizing trial findings to a complex survey. We propose and investigate ways to incorporate survey weights in this context. We examine the performance of our proposed estimator through simulations in comparison to estimators that ignore the complex survey design. We then apply the methods to generalize findings from two trials-a lifestyle intervention for blood pressure reduction and a web-based intervention to treat substance use disorders-to their respective target populations using population data from complex surveys. The work highlights the importance in properly accounting for the complex survey design when generalizing trial findings to a population represented by a complex survey sample.
© 2020 John Wiley & Sons, Ltd.

Entities:  

Keywords:  causal inference; complex survey data; generalizability; propensity scores; transportability

Mesh:

Year:  2020        PMID: 33241607      PMCID: PMC8034867          DOI: 10.1002/sim.8822

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  23 in total

1.  Premier: a clinical trial of comprehensive lifestyle modification for blood pressure control: rationale, design and baseline characteristics.

Authors:  Laura P Svetkey; David W Harsha; William M Vollmer; Victor J Stevens; Eva Obarzanek; Patricia J Elmer; Pao Hwa Lin; Catherine Champagne; Denise G Simons-Morton; Mikel Aickin; Michael A Proschan; Lawrence J Appel
Journal:  Ann Epidemiol       Date:  2003-07       Impact factor: 3.797

2.  External Validity in Policy Evaluations that Choose Sites Purposively.

Authors:  Robert B Olsen; Larry L Orr; Stephen H Bell; Elizabeth A Stuart
Journal:  J Policy Anal Manage       Date:  2013

3.  Beyond efficacy: the STAR*D trial.

Authors:  Thomas R Insel
Journal:  Am J Psychiatry       Date:  2006-01       Impact factor: 18.112

4.  Super learner.

Authors:  Mark J van der Laan; Eric C Polley; Alan E Hubbard
Journal:  Stat Appl Genet Mol Biol       Date:  2007-09-16

5.  Treatment Prediction, Balance, and Propensity Score Adjustment.

Authors:  Erica E M Moodie; David A Stephens
Journal:  Epidemiology       Date:  2017-09       Impact factor: 4.822

6.  Generalizing evidence from randomized clinical trials to target populations: The ACTG 320 trial.

Authors:  Stephen R Cole; Elizabeth A Stuart
Journal:  Am J Epidemiol       Date:  2010-06-14       Impact factor: 4.897

Review 7.  Large-scale randomized evidence: large, simple trials and overviews of trials.

Authors:  R Peto; R Collins; R Gray
Journal:  J Clin Epidemiol       Date:  1995-01       Impact factor: 6.437

8.  Assessing methods for generalizing experimental impact estimates to target populations.

Authors:  Holger L Kern; Elizabeth A Stuart; Jennifer Hill; Donald P Green
Journal:  J Res Educ Eff       Date:  2016-01-14

9.  Super-Learning of an Optimal Dynamic Treatment Rule.

Authors:  Alexander R Luedtke; Mark J van der Laan
Journal:  Int J Biostat       Date:  2016-05-01       Impact factor: 0.968

10.  Generalizing Evidence from Randomized Trials using Inverse Probability of Sampling Weights.

Authors:  Ashley L Buchanan; Michael G Hudgens; Stephen R Cole; Katie R Mollan; Paul E Sax; Eric S Daar; Adaora A Adimora; Joseph J Eron; Michael J Mugavero
Journal:  J R Stat Soc Ser A Stat Soc       Date:  2018-02-26       Impact factor: 2.483

View more
  4 in total

1.  Generalizing trial evidence to target populations in non-nested designs: Applications to AIDS clinical trials.

Authors:  Fan Li; Ashley L Buchanan; Stephen R Cole
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2022-03-17       Impact factor: 1.680

2.  On the Use of Covariate Supersets for Identification Conditions.

Authors:  Paul N Zivich; Bonnie E Shook-Sa; Jessie K Edwards; Daniel Westreich; Stephen R Cole
Journal:  Epidemiology       Date:  2022-04-05       Impact factor: 4.860

3.  Target validity: Bringing treatment of external validity in line with internal validity.

Authors:  Catherine R Lesko; Benjamin Ackerman; Michael Webster-Clark; Jessie K Edwards
Journal:  Curr Epidemiol Rep       Date:  2020-06-30

4.  Universal adaptability: Target-independent inference that competes with propensity scoring.

Authors:  Michael P Kim; Christoph Kern; Shafi Goldwasser; Frauke Kreuter; Omer Reingold
Journal:  Proc Natl Acad Sci U S A       Date:  2022-01-25       Impact factor: 11.205

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.